These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21013248)

  • 1. Studies on synthetic antimalarial drugs; a comparison of the therapeutic actions of 3349 and of mepacrine hydrochloride on acute attacks of benign tertian malaria.
    ADAMS AR; SANDERSON G
    Ann Trop Med Parasitol; 1945 Dec; 39():180. PubMed ID: 21013248
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on synthetic antimalarial drugs; a preliminary investigation of the therapeutic action of 3349 on acute attacks of benign tertian malaria.
    ADAMS AR; SANDERSON G
    Ann Trop Med Parasitol; 1945 Dec; 39():165-8. PubMed ID: 21013245
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on synthetic antimalarial drugs; results of a preliminary investigation of the therapeutic action of 4888 (paludrine) on acute attacks of benign tertian malaria.
    ADAMS AR; MAEGRAITH BG
    Ann Trop Med Parasitol; 1945 Dec; 39():225-31. PubMed ID: 21013255
    [No Abstract]   [Full Text] [Related]  

  • 4. Mepacrine metabolism in recurring benign tertian malaria.
    BROWN M; RENNIE JL
    Ann Trop Med Parasitol; 1946 Dec; 40(3-4):337-46. PubMed ID: 20289235
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of benign tertian malaria with mepacrine; an investigation of 247 cases of apparent failure.
    BROWN M; RENNIE JL
    Ann Trop Med Parasitol; 1946 Jul; 40():190-8. PubMed ID: 20997903
    [No Abstract]   [Full Text] [Related]  

  • 6. Relapsing benign tertian malaria treated with 4430.
    JOHNSTONE RD
    Ann Trop Med Parasitol; 1946 Dec; 40(3-4):330-2. PubMed ID: 20289233
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on synthetic antimalarial drugs; a preliminary investigation of the therapeutic action of 3349 on acute attacks of malignant tertian malaria.
    ADAMS AR; SANDERSON G
    Ann Trop Med Parasitol; 1945 Dec; 39():169-72. PubMed ID: 21013246
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on synthetic antimalarial drugs; further investigation of the therapeutic action of 3349 on benign tertian and on malignant tertian malaria infections.
    ADAMS AR; SANDERSON G
    Ann Trop Med Parasitol; 1945 Dec; 39():173-9. PubMed ID: 21013247
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on synthetic antimalarial drugs; results of a preliminary investigation of the therapeutic action of 4888 (paludrine) on acute attacks of malignant tertian malaria.
    MAEGRAITH BG; ADAMS AR
    Ann Trop Med Parasitol; 1945 Dec; 39():232-6. PubMed ID: 21013256
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of quinine and quinacrine in the treatment of the clinical attacks of vivax malaria.
    GORDON HH; CHRISTIANSON HB; LIPPINCOTT SW
    South Med J; 1946 Aug; 39(8):631-4. PubMed ID: 20993246
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative efficiency of quinacrine (atabrine) and quinine in treatment of acute attacks of vivax malaria.
    MOST H; HAYMAN JM
    Am J Med Sci; 1946 Mar; 211():320-4. PubMed ID: 21017159
    [No Abstract]   [Full Text] [Related]  

  • 12. A preliminary report on the single-dose therapeutic value of the antimalarial; drugs in cases of benign tertian malaria together with a note on the prophylactic action of the same compounds.
    HALAWANI A; BAZ II
    J Egypt Med Assoc; 1950; 33(6):604-14. PubMed ID: 14784974
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of an investigation of the therapeutic action of pentaquin on acute attacks of benign tertian malaria.
    MONK JF
    Trans R Soc Trop Med Hyg; 1948 Mar; 41(5):663-8. PubMed ID: 18912195
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of an investigation of the therapeutic action of paludrine and pamaquin on acute attacks of benign tertian malaria.
    MONK JF
    Trans R Soc Trop Med Hyg; 1948 Mar; 41(5):657-62. PubMed ID: 18912194
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the efficacy of four suppressive antimalarial drugs in the treatment of sporozoite induced vivax malaria.
    JONES R; EICHELBERGER L
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():84. PubMed ID: 20248586
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment on malaria with single doses of mepacrine, chloroquine and amodiaquin.
    BORODA C
    West Afr Med J; 1955 Sep; 4(3):144-8. PubMed ID: 13274779
    [No Abstract]   [Full Text] [Related]  

  • 17. [The phenomenon of the delayed initial attack of tertian malaria].
    Silbermann MH; Stuiver PC
    Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1984-7. PubMed ID: 1407184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of the plasma concentration of quinacrine to its antimalarial activity.
    MARSHALL EK; DEARBORN EH
    J Pharmacol Exp Ther; 1946 Oct; 88(2):142-53. PubMed ID: 20274536
    [No Abstract]   [Full Text] [Related]  

  • 19. Pamaquin; curative antimalarial activity in vivax malaria.
    BERLINER RW; TAGGART JV
    Fed Proc; 1946; 5(1 Pt 2):165. PubMed ID: 21064280
    [No Abstract]   [Full Text] [Related]  

  • 20. Modern antimalarial therapy.
    PFEIFFER CC
    Mod Hosp; 1952 Aug; 79(2):106-8. PubMed ID: 12992919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.